A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon®) in Asian women undergoing ovarian stimulation for IVF/ICSI

Journal of Assisted Reproduction and Genetics

Volumn 19, Issue 10, 2002, Pages 470-476

  Hoomans, Eric H M ^a   Mulder, Bernard B ^a  

^a NV ORGANON   (Netherlands)

Author keywords

Dosing; ICSI; IVF; Puregon ; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ECTOPIC PREGNANCY; ETHNOLOGY; FEMALE; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MICTURITION DISORDER; MULTICENTER STUDY; OOCYTE; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PAIN; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ASIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; RECOMBINANT PROTEINS;

EID: 0036773437     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020358419073     Document Type: Article

References (13)

1. Out HJ, Mannaerts BMJL, Driessen SG, Coelingh Bennink HJ: A prospective, randomized, assessor-blind, multicenter study comparing recombinant follicle-stimulating hormone (Puregon vs Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-2540
2. Devroey P, Tournaye H, van Steirteghem A, Hendrix P, Out HJ: The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. Hum Reprod 1998;13:565-566
3. Out HJ, Lindenberg S, Mikkelsen AL, Eldar-Geva T, Healy DL, Leader A, Rodriguez-Escudero FJ, Garcia-Velasco JA, Pellicer A: A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. Hum Reprod 1999;14:622-627
4. Out HJ, David I, Ron-El R, Friedler S, Shalev E, Geslevich J, Dor J, Shulman A, Ben-Rafael Z, Fisch B, Dirnfeld M: A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum Reprod 2001;16:1104-1109
5. CPMP Working Party on Efficacy of Medicinal Products: Good Clinical Practice for trials on medicinal products in the European Community. Pharmacol Toxicol 1990;67:361-372
6. Cochran WG: The combination of estimates from different experiments. Biometrics 1954;10:101-129
7. Cochran WG: Some methods for strengthening the common tests. Biometrics 1954;10:417-451
8. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-965
9. van Hooff MHA, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA: Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomized study. Hum Reprod 1993;8:369-373
10. Jones HW Jr, Out HJ, Hoomans EHM, Driessen SGAJ, Coelingh Bennink HJT: Cryopreservation: The practicalities of evaluation. Hum Reprod 1997;12:1522-1524
11. Out HJ, Driessen SGAJ, Mannaerts BMJL, Coelingh Bennink HJT: Recombinant follicle stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in vitro fertilization than urinary gonadotropins. Fertil Steril 1997;68:138-142
12. Ubaldi F, Camus M, Smitz J, Coelingh Bennink H, van Steirteghem A, Devroey P: Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996;66:275-280
13. Out HJ, Braat DDM, Lintsen BME, Gurgan T, Bukulmez O, Gokmen O, Keles G, Caballero P, Gonzalez JM, Fabregues F, Balasch J, Roulier R: Increasing the daily dose of recombinant follicle stimulating hormone Puregon does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod 2000;15:29-35